Correlation Between C4 Therapeutics and Agios Pharm
Can any of the company-specific risk be diversified away by investing in both C4 Therapeutics and Agios Pharm at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining C4 Therapeutics and Agios Pharm into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between C4 Therapeutics and Agios Pharm, you can compare the effects of market volatilities on C4 Therapeutics and Agios Pharm and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in C4 Therapeutics with a short position of Agios Pharm. Check out your portfolio center. Please also check ongoing floating volatility patterns of C4 Therapeutics and Agios Pharm.
Diversification Opportunities for C4 Therapeutics and Agios Pharm
-0.4 | Correlation Coefficient |
Very good diversification
The 3 months correlation between CCCC and Agios is -0.4. Overlapping area represents the amount of risk that can be diversified away by holding C4 Therapeutics and Agios Pharm in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Agios Pharm and C4 Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on C4 Therapeutics are associated (or correlated) with Agios Pharm. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Agios Pharm has no effect on the direction of C4 Therapeutics i.e., C4 Therapeutics and Agios Pharm go up and down completely randomly.
Pair Corralation between C4 Therapeutics and Agios Pharm
Given the investment horizon of 90 days C4 Therapeutics is expected to generate 3.34 times more return on investment than Agios Pharm. However, C4 Therapeutics is 3.34 times more volatile than Agios Pharm. It trades about 0.04 of its potential returns per unit of risk. Agios Pharm is currently generating about 0.09 per unit of risk. If you would invest 323.00 in C4 Therapeutics on August 29, 2024 and sell it today you would earn a total of 96.00 from holding C4 Therapeutics or generate 29.72% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Very Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
C4 Therapeutics vs. Agios Pharm
Performance |
| Timeline |
| C4 Therapeutics |
| Agios Pharm |
C4 Therapeutics and Agios Pharm Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with C4 Therapeutics and Agios Pharm
The main advantage of trading using opposite C4 Therapeutics and Agios Pharm positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if C4 Therapeutics position performs unexpectedly, Agios Pharm can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Agios Pharm will offset losses from the drop in Agios Pharm's long position.| C4 Therapeutics vs. Shattuck Labs | C4 Therapeutics vs. Eliem Therapeutics | C4 Therapeutics vs. Prelude Therapeutics | C4 Therapeutics vs. Monte Rosa Therapeutics |
| Agios Pharm vs. Mereo BioPharma Group | Agios Pharm vs. Blueprint Medicines Corp | Agios Pharm vs. Day One Biopharmaceuticals | Agios Pharm vs. Biomarin Pharmaceutical |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the AI Portfolio Architect module to use AI to generate optimal portfolios and find profitable investment opportunities.
Other Complementary Tools
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Commodity Directory Find actively traded commodities issued by global exchanges | |
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios |